AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 20, 2016
5262_dirs_2016-07-20_bda4d9ad-0cee-4231-8b67-130e45cc43eb.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6662E
GlaxoSmithKline PLC
19 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Dr K Slaoui
b)
Position/status
PCA of Dr M M Slaoui (Chairman, Global Vaccines)
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Nature of the transaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 14 July 2016.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| $44.190 | 26.288 |
d)
Aggregated information
Aggregated volume Price
n/a (single transaction)
e)
Date of the transaction
2016-07-18
f)
Place of the transaction
NYSE (XNYS)
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHKKLFFQDFBBBK
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'gWlAkDbRSJ_t8G47zdHLvGbgppg79IxpTrqjWJVpGfDAQG3HQYx1uCqdc3-rSn4hpLGxq_yflngL3dBWyQBTR8E8Q4609vXl_Xhju6wCX9s1:Le-iT2U6LRoYd935CsToPXQrSq6x5jmLL8Iq_iP3RuAx0UDM4iKPVbx_k6DIt3yfFQvkQtFfG-1-yBPTzVY-qFlCPeALLsLXLWJf5qEP0Sk1'}});//]]>